Yervoy and Glimepiride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Yervoy (ipilimumab) and Glimepiride (glimepiride). Common drug interactions include acute respiratory distress syndrome among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Yervoy and Glimepiride. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

On Jul, 17, 2026

39 people who take Yervoy and Glimepiride together, and have interactions are studied.

Yervoy and Glimepiride drug interactions.

What are the common drug interactions of Yervoy and Glimepiride, by gender? *:

female:

Acute respiratory distress syndrome
Cholangitis sclerosing (infection and obstruction of bile duct)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Interstitial lung disease
Malignant neoplasm progression (cancer tumour came back)
Asthenia (weakness)
Cardiac failure congestive
Colitis (inflammation of colon)
Death
Diarrhoea

male:

Death
Diarrhoea
Hepatic failure (liver failure)
Hepatitis acute
Hyperthyroidism (over activity of the thyroid gland)
Insomnia (sleeplessness)
Malignant neoplasm progression (cancer tumour came back)
Neuropathy peripheral (surface nerve damage)
Weight increased
Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Yervoy and Glimepiride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Death
Dehydration (dryness resulting from the removal of water)
Liver disorder (liver diseases)
Type 1 diabetes mellitus
Anaemia (lack of blood)

60+:

Death
Malignant neoplasm progression (cancer tumour came back)
Hepatitis acute
Hyperthyroidism (over activity of the thyroid gland)
Insomnia (sleeplessness)
Interstitial lung disease
Weight decreased
Weight increased
Aphasia (damage to the parts of the brain that control language)
Asthenia (weakness)

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 11 people, 28.21%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 12.82%
Type 2 Diabetes: 2 people, 5.13%
Renal Cell Carcinoma (a kidney cancer): 2 people, 5.13%
Neuroendocrine Tumor: 2 people, 5.13%
Neuroendocrine Carcinoma Of The Skin (a rare type of cancer that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun): 2 people, 5.13%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 5.13%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 5.13%
Hepatocellular Carcinoma (liver cancer): 2 people, 5.13%
Gastric Cancer (stomach cancer): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Yervoy and Glimepiride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously